[ad_1]
Company photo
The United Kingdom (UK) has become the first country in the world to approve a COVID-19 vaccine developed by Pfizer and BioNTech for widespread use. The UK has indicated that the product could be distributed during the week.
The report was supplemented by a quote from a Pfizer executive.
The British Independent Medicines and Health Products Safety Agency (MHRA) has stated that the vaccine, which has been shown to protect 95%, is safe and can be used by the general public.
The government today accepted the MHRA’s recommendation to approve the use of the Pfizer-BioNTech vaccine against COVID-19, the UK Department of Health said in a statement.
The vaccine will be available across the UK from next week, and the department of pridr and paymjo will give priority to nursing home residents and healthcare professionals and carers.
After months of clinical trials and in-depth data analysis, the MHRA concluded that the vaccine met its general standards for safety, quality and efficacy, the statement added.
For a larger vaccination program to be successful, it is vital that everyone continues to play their role and adhere to the necessary containment in our areas so that we can further suppress the virus and allow the NHS to function without congestion, according to the report.
Albert Bourla, a director at Pfizer, said it was a historic moment in the fight against COVID-19.
This edition has been a goal we have been working towards since we first announced that science will win … Congratulations to the MHRA, who have been very careful and taken timely action to help protect UK businesses, said.
Faster confirmation
The UK has already paid 40 million. vaccine doses, utectinically, to allow vaccination of 20 million. because you have to administer two doses each. around 68 million people live in the country. moni.
The first 10 million units. The ampoule will arrive in the UK in the next few days.
The BBC reports that this is probably the most recent vaccination and validation of the vaccine, lasting only a decade.
Pfizer and BioNTech say they expect other access authorities to make a decision in the coming days and weeks.
V. Recalling that the European Medicines Agency announced on Tuesday that it would decide before December 29 whether to approve the use of the COVID-19 vaccine developed by the German pharmaceutical company BioNTech and its US partner Pfizer as a matter of urgency and makes a decision earlier that Modern preparation developed.
The European Medicines Agency (EMA) has confirmed that it has received official requests from both vaccine manufacturers for the authorization of laboratory-developed vaccines.
The EU has signed an agreement on behalf of all Member States to purchase one million doses of vaccines from BioNTech, CureVac, AstraZeneca, Moderna and Sanofi, provided that these products can be placed on the market once the necessary authorizations have been granted.
Rayti komentar
[ad_2]
